Serum cytokeratin 18 as a biomarker for gastric cancer

Author： Oyama Katsunobu   Fushida Sachio   Kinoshita Jun   Okamoto Koichi   Makino Isamu   Nakamura Keishi   Hayashi Hironori   Inokuchi Masafumi   Nakagawara Hisatoshi   Tajima Hidehiro   Fujita Hideto   Takamura Hiroyuki   Ninomiya Itasu   Kitagawa Hirohisa   Fujimura Takashi   Ohta Tetsuo  

Publisher： Springer Publishing Company

ISSN： 1591-8890

Source： Clinical and Experimental Medicine, Vol.13, Iss.4, 2013-11, pp. : 289-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Expression of Stanniocalcin 1 as a Potential Biomarker of Gastric Cancer

By  

Oncology, Vol. 83, Iss. 3, 2012-08 ,pp. : 158-164

Karger

Access to resources Recommend Favorite

Response to Serum cytokeratin‐18 fragment levels predict development of type 2 diabetes mellitus in adult patients with NAFLD

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2622-2622

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum cytokeratin‐18 fragment levels predict development of type 2 diabetes mellitus in adult patients with NAFLD

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2621-2621

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Diagnostic Value of Cytokeratin 5/6, 14, 17, and 18 Expression in Human Non-Small Cell Lung Cancer

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 333-340

Karger

Access to resources Recommend Favorite

Serum peptidome profiling in patients with gastric cancer

By Yang Juan  

Clinical and Experimental Medicine, Vol. 12, Iss. 2, 2012-06 ,pp. : 79-87

Springer Publishing Company

Access to resources Recommend Favorite